Company / Interest Expense per Share
ARS Pharmaceuticals, Inc. Interest Expense per Share History
FY2020-FY2021 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense per Share
$0.00
FY2021
5-year range
$0.00 / $0.00
FY2020-FY2021
Trend
+136.8%
vs FY2020
Sector context
#38 of 43
Health Care
What the data says
ARS Pharmaceuticals, Inc.'s interest expense per share of $0.00 is lower than 88% of companies in the Health Care sector (FY2021).
Based on SEC 10-K filings.
0.00 in FY2021.
Health Care sector context is included.
Interest Expense per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 12% in Health CareTop 12% of 43This company $0.00 Sector average $18.61
▼
-100.0% below sector average
Key checks
Key Insights
- In FY2021, interest expense per share increased 136.8% year-over-year.
- Ranks #38 out of 43 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -1.44 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest Expense per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | $0.00 | +136.8% |
| FY2020 | -$0.01 | - |
As of FY2021 · SEC 10-K · Updated Jun 30, 2026